{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:07:40Z","timestamp":1777712860767,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:00:00Z","timestamp":1369785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11845-013-0960-8","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T18:30:13Z","timestamp":1369765813000},"page":"703-706","source":"Crossref","is-referenced-by-count":13,"title":["Treatment of seborrheic dermatitis: comparison of sertaconazole 2\u00a0% cream versus pimecrolimus 1\u00a0% cream"],"prefix":"10.1007","volume":"182","author":[{"given":"M.","family":"Goldust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Raghifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,29]]},"reference":[{"key":"960_CR1","first-page":"e1","volume":"12","author":"ZD Draelos","year":"2013","unstructured":"Draelos ZD, Feldman SR, Butners V et al (2013) Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study. J Drugs Dermatol 12:e1\u2013e6","journal-title":"J Drugs Dermatol"},{"key":"960_CR2","first-page":"147","volume":"114","author":"A Nowinska","year":"2012","unstructured":"Nowinska A, Wylegala E, Tarnawska D et al (2012) Meibomian gland dysfunction\u2014review. Klin Oczna 114:147\u2013152","journal-title":"Klin Oczna"},{"key":"960_CR3","doi-asserted-by":"crossref","unstructured":"Goldust M, Rezaee E (2013) The efficacy of topical ivermectin vs. malation 0.5% lotion for the treatment of scabies. J Dermatolog Treat (Epub 2013 Mar 8)","DOI":"10.3109\/09546634.2013.782093"},{"key":"960_CR4","doi-asserted-by":"crossref","unstructured":"Kwon SH, Jeong MY, Park KC et al (2013) A new therapeutic option for facial seborrhoeic dermatitis: indole-3-acetic acid photodynamic therapy. J Eur Acad Dermatol Venereol. doi: 10.1111\/jdv.12070","DOI":"10.1111\/jdv.12070"},{"key":"960_CR5","doi-asserted-by":"crossref","unstructured":"Goldust M, Ranjkesh MR, Amirinia M et al (2012) Sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis. J Dermatolog Treat (Epub 2013 Feb 24)","DOI":"10.3109\/09546634.2012.755251"},{"key":"960_CR6","doi-asserted-by":"crossref","unstructured":"Lotti T, Goldust M, Rezaee E (2013) Treatment of seborrheic dermatitis, Comparison of sertaconazole 2% cream vs. ketoconazole 2% cream. J Dermatolog Treat (Epub 2013 Feb 26)","DOI":"10.3109\/09546634.2013.777154"},{"key":"960_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0974-7753.96907","volume":"4","author":"E Wang","year":"2012","unstructured":"Wang E, Lee JS, Hee TH (2012) Is Propionibacterium acnes associated with hair casts and alopecia? Int J Trichol 4:93\u201397","journal-title":"Int J Trichol"},{"key":"960_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.5604\/17322693.1019648","volume":"66","author":"E Trznadel-Grodzka","year":"2012","unstructured":"Trznadel-Grodzka E, Blaszkowski M, Rotsztejn H (2012) Investigations of seborrheic dermatitis. Part II. Influence of itraconazole on the clinical condition and the level of selected cytokines in seborrheic dermatitis. Postepy Hig Med Dosw (Online). 66:848\u2013854","journal-title":"Postepy Hig Med Dosw (Online)."},{"key":"960_CR9","doi-asserted-by":"crossref","unstructured":"Goldust M, Rezaee E, Raghifar R (2013) Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cutan Ocul Toxicol (Epub 2013 Feb 25)","DOI":"10.3109\/15569527.2013.768258"},{"key":"960_CR10","first-page":"1194","volume":"11","author":"LH Kircik","year":"2012","unstructured":"Kircik LH, Del Rosso JQ (2012) The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol 11:1194\u20131198","journal-title":"J Drugs Dermatol"},{"key":"960_CR11","first-page":"251","volume":"20","author":"A Mohebbipour","year":"2012","unstructured":"Mohebbipour A, Saleh P, Goldust M et al (2012) Treatment of scabies: comparison of ivermectin vs. lindane lotion 1%. Acta Dermatovenerol Croat 20:251\u2013255","journal-title":"Acta Dermatovenerol Croat"},{"key":"960_CR12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/SMJ.0b013e31826f5d17","volume":"105","author":"CR Na","year":"2012","unstructured":"Na CR, Wang S, Kirsner RS et al (2012) Elderly adults and skin disorders: common problems for nondermatologists. South Med J 105:600\u2013606","journal-title":"South Med J"},{"key":"960_CR13","doi-asserted-by":"crossref","unstructured":"Goldust M, Babae NS, Rezaee E et al (2013) Comparative trial of permethrin 5% versus lindane 1% for the treatment of scabies. J Dermatolog Treat (Epub 2013 Jan 20)","DOI":"10.3109\/09546634.2012.723122"},{"key":"960_CR14","first-page":"20","volume":"5","author":"T Schlesinger","year":"2012","unstructured":"Schlesinger T, Rowland PC (2012) Efficacy and safety of a low-molecular weight hyaluronic acid topical gel in the treatment of facial seborrheic dermatitis. J Clin Aesthet Dermatol 5:20\u201323","journal-title":"J Clin Aesthet Dermatol"},{"key":"960_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1346-8138.2011.01481.x","volume":"39","author":"M Goldust","year":"2012","unstructured":"Goldust M, Rezaee E, Hemayat S (2012) Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol 39:545\u2013547","journal-title":"J Dermatol"},{"key":"960_CR16","first-page":"530","volume":"61","author":"A Sadeghpour","year":"2011","unstructured":"Sadeghpour A, Mansour R, Aghdam HA et al (2011) Comparison of trans patellar approach and medial parapatellar tendon approach in tibial intramedullary nailing for treatment of tibial fractures. J Pak Med Assoc 61:530\u2013533","journal-title":"J Pak Med Assoc"},{"key":"960_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D39ZQ059N5","volume":"9","author":"I Brownell","year":"2003","unstructured":"Brownell I, Quan LT, Hsu S (2003) Topical pimecrolimus in the treatment of seborrheic dermatitis. Dermatol Online J 9:13","journal-title":"Dermatol Online J"},{"key":"960_CR18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1368-5031.2005.00587.x","volume":"59","author":"P Gisondi","year":"2005","unstructured":"Gisondi P, Ellis CN, Girolomoni G (2005) Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract 59:969\u2013974","journal-title":"Int J Clin Pract"},{"key":"960_CR19","first-page":"1135","volume":"10","author":"JM Weinberg","year":"2011","unstructured":"Weinberg JM, Koestenblatt EK (2011) Treatment of interdigital tinea pedis: once-daily therapy with sertaconazole nitrate. J Drugs Dermatol 10:1135\u20131140","journal-title":"J Drugs Dermatol"},{"key":"960_CR20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3923\/pjbs.2011.950.953","volume":"14","author":"A Sadighi","year":"2011","unstructured":"Sadighi A, Elmi A, Jafari MA et al (2011) Comparison study of therapeutic results of closed tibial shaft fracture with intramedullary nails inserted with and without reaming. Pak J Biol Sci 14:950\u2013953","journal-title":"Pak J Biol Sci"},{"key":"960_CR21","first-page":"107","volume":"85","author":"C Borelli","year":"2010","unstructured":"Borelli C, Korting HC, Bodeker RH et al (2010) Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis. Cutis 85:107\u2013111","journal-title":"Cutis"},{"key":"960_CR22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1684\/ejd.2011.1301","volume":"21","author":"M Goldust","year":"2011","unstructured":"Goldust M, Golforoushan F, Rezaee E (2011) Treatment of solar lentigines with trichloroacetic acid 40% vs. cryotherapy. Eur J Dermatol 21:426\u2013427","journal-title":"Eur J Dermatol"},{"key":"960_CR23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaad.2012.06.045","volume":"67","author":"KP Boyd","year":"2012","unstructured":"Boyd KP, Vincent B, Andea A et al (2012) Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma. J Am Acad Dermatol 67:1375\u20131379","journal-title":"J Am Acad Dermatol"},{"key":"960_CR24","doi-asserted-by":"crossref","first-page":"e42628","DOI":"10.1371\/journal.pone.0042628","volume":"7","author":"I Cohen","year":"2012","unstructured":"Cohen I, Birnbaum RY, Leibson K et al (2012) ZNF750 is expressed in differentiated keratinocytes and regulates epidermal late differentiation genes. PLoS ONE 7:e42628","journal-title":"PLoS ONE"},{"key":"960_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/ecp.11.68","volume":"5","author":"CU Ang-Tiu","year":"2012","unstructured":"Ang-Tiu CU, Meghrajani CF, Maano CC (2012) Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol 5:91\u201397","journal-title":"Expert Rev Clin Pharmacol"},{"key":"960_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2133.2004.06208.x","volume":"151","author":"D Rigopoulos","year":"2004","unstructured":"Rigopoulos D, Ioannides D, Kalogeromitros D et al (2004) Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol 151:1071\u20131075","journal-title":"Br J Dermatol"},{"key":"960_CR27","first-page":"1066","volume":"142","author":"A Firooz","year":"2006","unstructured":"Firooz A, Solhpour A, Gorouhi F et al (2006) Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol 142:1066\u20131067","journal-title":"Arch Dermatol"},{"key":"960_CR28","first-page":"895","volume":"10","author":"BE Elewski","year":"2011","unstructured":"Elewski BE, Cantrell WC (2011) An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis. J Drugs Dermatol 10:895\u2013899","journal-title":"J Drugs Dermatol"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-013-0960-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-013-0960-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-013-0960-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T01:29:29Z","timestamp":1645579769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-013-0960-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,29]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1007\/s11845-013-0960-8","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,29]]}}}